Advertisement

Indian Journal of Clinical Biochemistry

, Volume 21, Issue 2, pp 181–188 | Cite as

Effect ofOcimum sanctum (Tulsi) and vitamin E on biochemical parameters and retinopathy in streptozotocin induced diabetic rats

  • Halim Eshrat M. Email author
  • A. K. Mukhopadhyay
Article

Abstract

This study was carried out to see the effect of the aqueous extract ofOcitum sanctum Linn (Tulsi) with Vitamin E on biochemical parameters and retinopathy in the streptozotocin-induced diabetic albino male rats. Adult albino male rats weighing 150–200 gm were made diabetic by intraperitoneal injection of streptozotocin in the dose 60 mg/kg in citrate buffer (pH 6.3). The diabetic animals were left for one month to develop retinopathy. Biochemical parameters like plasma glucose, oral glucose tolerance and glycosylated hemoglobin HbA1c, were measured along with lipid profile, and enzymes like glutathione peroxidase (GPX), lipid peroxidase (LPO), superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST) in normal, untreated diabetic rats and diabetic rats treated withOcimum sanctum L extracts and vitamin E. Fluorescein angiography test was done for assessing retinopathy. Results on biochemical parameters were analyzed statistically by using ANOVA followed by Dunnet's ‘t’-test. A p-value of <0.05 was considered as significant. Evaluation of biochemical profile in treated groups showed statistically significant reduction in plasma levels of glucose, HbA1c, lipid profile and LPO, and elevation of GPX, SOD, CAT and GST. Treatment of the diabetic animals withOcimum sanctum and Vitamin E, alone and in combination for 16 weeks showed reversal of most of the parameters studied including plasma glucose levels. Angiography showed improvement in retinal changes following combined antidiabetic treatment.

Key Words

Ocimum sanctum Vitamin E Diabetes mellitus Diabetic retinopathy Lipid peroxidation Antioxidants 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Robert, N. and Frank. (2004) Diabetic Retinopathy. New England Journal of Medicine 350, 48–58.CrossRefGoogle Scholar
  2. 2.
    Klein, R. and Klein, B.E.K. (1995) Vision disorders in diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Bethesda, M D, NIH (Pub 1). 95 (1468), 293–338.Google Scholar
  3. 3.
    Rahi, J. S., Sripathi, S., Gilbert, C.E., Foster, A. (1995) Child hood blindness in India: Causes in 1318 blind school children in nine states. Eye 9, 545–550.PubMedGoogle Scholar
  4. 4.
    Riordan, E. P, Eye. (2003) In current Medical Diagnosis and Treatment. 42nd ed. Tierney L. M., Mcphee, S. J., Papadakis, M.A., Eds. (New York), Lange Medical Books Mc Graw-Hill, 46, 177–1778.Google Scholar
  5. 5.
    Kumar, A. (1998) Diabetic blindness in India, The emerging scenario. Indian J Ophthalmol 46, 65–69.PubMedGoogle Scholar
  6. 6.
    Harris, M. 1, Hadden, W.C., Knowles, W.C. and Bennett, P.H. (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20–74 yr. Diabetes 36, 523–534.PubMedCrossRefGoogle Scholar
  7. 7.
    U K Prospective. Diabetes Study Group. (1998) Intensive blood—glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in- patients with type 2 diabetes (UKPDS33). Lancet 352, 837–853.CrossRefGoogle Scholar
  8. 8.
    Jain, S. K. (1999) Should high—dose vitamin E supplementation be recommended to patients? Diabetes Care 22, 8, 1242–1244.PubMedCrossRefGoogle Scholar
  9. 9.
    Sivaram, P. (1994) In New Developments in cardiology and cardiac surgery. Eds. Tehran, N., Kumar, A. Escort Heart Institute and Research Center, (New Delhi), 1.Google Scholar
  10. 10.
    Jain, S.K. (1996) The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids, suppl S. 86, 90–94.Google Scholar
  11. 11.
    Eshrat, Halim M.A. Hussain, Kaiser Jamil and Mala Rao. (2001) Hypoglycemic, Hypolipidemic and antioxidant properties of Tulsi (Ocimum sanctum Linn) on streptozotocin induced diabetes in rats. Ind J Clin Biochem, 2, 190–194.Google Scholar
  12. 12.
    Eshrat, H. M. (2002) Reversal of diabetic retinopathy in streptozotocin induced diabetic rats using traditional Indian antidiabetic plant,Azadirachta indica (L.). Ind. J. Clin. Biochem 17, 115–123.CrossRefGoogle Scholar
  13. 13.
    Eshrat, H. M. (2003) Lowering of blood sugar by water extract ofAzadirachta indica andAbroma augusta in diabetes rats. Ind.J. Exp. Biol, 41, 636–640.Google Scholar
  14. 14.
    Beers, R.F., Sizer, L.W. (1952) A spectro photometric method for measuring the break break down of hydrogen peroxide by catalase. J. Biol. Chem. 195, 133.PubMedGoogle Scholar
  15. 15.
    Aeibi, H., Catalase In., H.U., Berg, Meyer (ed). (1974) Methods in Enzymatic Analysis. Academic Press, New York, 673–684.Google Scholar
  16. 16.
    Saxena, A.K., Srivastava, P., Kale, R.K., Baqer, N.Z. (1993) Impaired antioxidant status in diabetic rat liver: Effect of vanadate. Biochem Pharmacol 45, 539–542.PubMedCrossRefGoogle Scholar
  17. 17.
    Lawrence, R.A., Burk, R.F. (1976) Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 71, 952–958.PubMedCrossRefGoogle Scholar
  18. 18.
    Gupta, D., Raju, J., Prakash, J., Baquer, N.Z. (1999) Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats; effect of a insulin and vanadate. Diabetes Res. Clin. Pract. 46, 1–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Halim, E. M. (2002) Hypoglycemic Hypolipidemic and antioxidant properties of combination ofCurcumin fromCurcuma Longa, Linn and partially purified product fromAbroma Augusta, Linn, in streptozotocin induced diabetes. Ind. J. Clin. Biochem. 17, 33–43.CrossRefGoogle Scholar
  20. 20.
    Ohkawa, H., Ohishi, N., Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbioturic acid reaction. Analytical Biochemistry 95, 351–358.PubMedCrossRefGoogle Scholar
  21. 21.
    Lowry, W.H., Rosebrough, N.J., Farr A.L., Randall, R.J. (1951) Protein measurement with the Folin Phenol reagent. J Biol Chem 193, 265–275.PubMedGoogle Scholar
  22. 22.
    Friedewald W.T., Levy, R.I., and Fred Rickson, D.S. (1972) Estimation of the concentration of low—density Lipoprotein in cholesterol in plasma without use of the preparative a ultracentrifuge. Clin Chem. 18 (6), 499–500.PubMedGoogle Scholar
  23. 23.
    Hyvarinen, L, and Hochheimer, B. F. (1974) Filter systems in fluorescein angiography Int Ophthalmol Clin, 14 (3), 49–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Wilkinson, C.P. (1986) The clinical examination. Limitation and over utilization of Angiographic services. Ophthalmology, 93, 410–404.Google Scholar
  25. 25.
    Garg, M.C., Ojha, S. and Bansal, D.D. (1996) Antioxidant status of streptozotocin diabetic rats. Ind. J. Exp. Biol, 34, 264–266.Google Scholar
  26. 26.
    Wolff, S. P., Dean, R. T. (1987) Glucose autoxidation and protein modification: The potential role of ‘auto oxidative glycosylation’ in diabetes. Biochem J, 245, 243–250.PubMedGoogle Scholar
  27. 27.
    The PKC-DRS Study Group (2005) Initial Results of the Protein Kinase C b Inhibitor Diabetic Retinopathy Study (PKC-DRS). Multicenter Randomized Clinical Trial Diabetes, 54, 2188–2197Google Scholar
  28. 28.
    Cusick, M., Chew, E.Y., Clemons, T.E., Klein, R., Klein, B.E.K. and Hubbard, L.D. (2002) Effect of antioxidant and Zinc supplements on development of diabetic retinopathy in the Age Related Eye Disease Study (AREDS). Invest Ophthalmol Vis Sci 43: E 1909.Google Scholar
  29. 29.
    Hammes, H. P., Xueliang Du, Edelstein, D, et al (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9, 294–299.PubMedCrossRefGoogle Scholar
  30. 30.
    The Diabetes Control and Complications Trial Research Group. (1997) Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial. Diabetes 46: 1829–1839.CrossRefGoogle Scholar
  31. 31.
    Sarkar, A., Lavania, S.C., Pandy, D.N., Pant, M.C. (1994) Changes in the blood lipid profile after administration ofOcimum sanctum (Tulsi) leaves in the normal albino rabbits. Indian J Physiol Pharmacol, 38 (4), 311–2.PubMedGoogle Scholar
  32. 32.
    Baynes, J., Thorpe, S. (1999) Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48, 1–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Yanpallewar, S.U., Raj, S., Kumar, M., Achary, A. (2004) Evaluation of antioxidant and neuroprotective effect ofOcimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Biochem Behar 79(1), 155–164.CrossRefGoogle Scholar
  34. 34.
    Sood, S., Narang, D., Dinda, A. K., Maulik, S. K. (2005) Chronic oral administration ofOcimum snctum Linn augments cardac endogenous antioxidants and prevents Isoproterenol induced myocardial necrosis in rats. J Pharm Pharmacol 57(1), 127–133.PubMedCrossRefGoogle Scholar
  35. 35.
    Gupta, S.K., Srivastava, S., Trivedi, D, Joshi, S., Halder, N. (2005) Ocimum sanctum modulates selenite—induced cataractogenic damage and prevents rat lens opacification. Curr Eye Res 30 (7), 583–591.PubMedCrossRefGoogle Scholar
  36. 36.
    Geetha, R. K., Vasudevan, D.M. (2004) Inhibition of lipid peroxidation by botanical extracts ofOcimum sanctum: in vivo and in Vitro studies. Life Sci 76 (1), 21–28.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical BIochemists of India 2006

Authors and Affiliations

  1. 1.Department of Laboratory MedicineAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations